Introduction
Despite advances in brain research, central nervous system disorders remain very difficult to treat as the majority of drugs do not cross the blood-brain barrier (BBB) (Pardridge, 2003) . Indeed, the BBB acts as an anatomical and transporter barrier notably due to the presence of tight junctions and the ATP-dependent efflux pump P-glycoprotein (P-gp) respectively. The BBB limits the ability of many drugs to penetrate brain tissue by restricting paracellular and transcellular transport. Ohnishi et al. (1995) have reported that the brain distribution of doxorubicin (DOX), an antitumoral agent widely used in the treatment of several cancers, is mainly restricted by P-glycoprotein on the BBB under normal physiological conditions. Consequently, DOX delivery to the brain is still a challenge for numerous research groups. Indeed, to circumvent the limited access of DOX into the brain, different approaches have been investigated including drug delivery systems such as liposomes (Saito et al, 2004) or nanoparticles (Gulyaev et al, 1999) , peptide-vector strategy using DOX linked to cationic peptides (Rousselle et al, 2001 ), P-gp modulator (Fenart et al., 1998) or osmotic pressure modification (Neuwelt et al., 1981) . A bradykinin analogue, RMP-7, can also increase the tight junction permeability of the endothelial cells and enhance delivery of therapeutic agents across the BBB (Bartus et al., 1996) . Interestingly, cyclodextrins (CDs) can be used as permeation enhancer on the BBB. Indeed, CDs are widely used to increase the delivery or bioavailability of drugs in nasal (Merkus et al., 1999) , ocular (Loftsson and Järvinen, 1999) , dermal (Matsuda and Arima, 1999) or oral field. For example, it was described on Caco-2 cell monolayer (as an intestinal model) that dimethyl-β-CD increased permeability of tacrolimus (an immunosuppressor) by its inhibitory effect on the Pgp-mediated efflux (Arima et al, 2001 ). As Caco-2 cell monolayer are often employed to predict toxicity or permeability for a drug towards the BBB (Lohmann et al, 2002) , it was of great interest to evaluate the role of CDs on DOX transport across the BBB. Recently, we This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on July 10, 2017 jpet.aspetjournals.org Downloaded from JPET #71845 5 have described the behaviour of various CDs on an in vitro model of BBB (Monnaert et al., 2004) . The γ-CD and hydroxypropyl-γ-CD (HP-γ-CD) have been found to be the less toxic CDs towards the brain capillary endothelial cells (BCEC) monolayer and were able to cross slightly the BBB. As these two γ-CDs and DOX formed an inclusion complex, their association has been studied to modify the P-gp efflux and BBB permeability in order to increase DOX delivery.
This article has not been copyedited and formatted. The final version may differ from this version. Characterization of cyclodextrin-doxorubicin complexes. The continuous variation method (Job's method) was employed to determine the stoichiometry of the complex (Connors, 1987) .
For each CD, a series of samples containing variable ratios (r varying from 0 to 1) of CD and DOX was prepared keeping the total concentration of species constant (10 µM in this present case). The samples were prepared in physiological buffer (Ringer HEPES: RH). The differences of absorption intensity at 479 nm in UV-visible spectroscopy (Lambda 19, Perkin
Elmer, Courtaboeuf, France) were measured in function of molar ratio. The plot of ∆abs.
[DOX] versus the mole ratio of DOX (r) was traced. The UV spectra's derivatives (recorded at 479 nM) were chosen, so that no effect from the refractive index relative to the CD was observed (Landy et al., 2000) .
The titration method was used to determine association constants. This method was applied for a fixed concentration of DOX (10 µM) and varying concentrations of CD. The
This article has not been copyedited and formatted. The final version may differ from this version. Standard deviation over A COMP is minimized relative to K f to obtain the 1:1 association constant.
Brain capillaries endothelial cells. BCEC were isolated and characterized as described by Méresse et al. (1989) . The use of cloned endothelial cells allowed us to obtain a pure endothelial cell population without contamination by pericytes. oligodendrocytes and 20% microglia were prepared from newborn rat cerebral cortex (Descamps et al., 2003) . After removing the meninges, the brain tissue was forced gently through a nylon sieve, as described by Booher and Sensenbrenner (1972) . Glial cells were plated on six multiwell dishes at a concentration of 1.2 x 10 5 cells/ml in 2 ml DMEM supplemented with 10% (v/v) fetal calf serum (Gibco Life Technologies, Auckland, New Zealand) and the medium was changed twice a week. Three weeks after seeding, cultures of glial cells were stabilized and used for co-culture.
Preparation of filters for co-culture. Culture plate inserts (Millicell PC 3 µm, 30 mm diameter; Millipore, SAS, Molsheim, France) were coated on the upper side with 150 µL of a 2 mg/ml solution of rat tail collagen containing 10 fold concentrated DMEM plus 0.3 M NaOH. The coated inserts were dried for 1 h at 37°C and were rinsed twice with water and once with calcium and magnesium free phosphate buffered saline (PBS-CMF) before being placed in complete medium.
Experimental method for co-culture. Cultures of glial cells were prepared as described above. After 3 weeks, coated filters were set in six multiwell dishes containing glial cells.
Endothelial cells were plated on their upper side in 1.5 ml of medium at a concentration of 4 x 10 5 cells/ml. The co-culture medium was the same as that for BCEC. Under these conditions, BCEC formed a confluent monolayer after 7 days. Experiments were performed 5 days after confluence.
Transport experiments. During the permeability study, RH solution was added to the lower compartment (abluminal side) of a six-well plate (2.5 ml per well). Using the same methodology, the integrity of the BCEC monolayer was checked by adding The amount of DOX, inulin or CD crossing the BBB was expressed as endothelial permeability (Pe). It was calculated in cm/min as described by Dehouck et al (1992) . In this Electrical resistance measurements. Electrical resistance of the cultures was measured using a Millicell-ERS apparatus (Millipore). In each experiment, the resistance of the collagencoated filter was measured and subtracted from the resistance of the cells on the filter to yield the resistance due to the endothelial monolayer itself. 
Results
Characterisation of γ-CD/DOX and HP-γ-CD/DOX complexes. The γ-or HP-γ-CD has been employed in order to modify the transport of DOX across the BBB. In aqueous medium, γ-CD forms an inclusion complex with DOX as proved by NMR (Djedaïni et al., 1990) , fluorescence (Husain et al., 1992) and absorbance spectroscopy (Bekers et al., 1990) . The stoichiometry has been determined to be 1:1 and the association constant value differed according to experimental technique varying between 200 and 1000 M -1
. As our transport experiments across the BBB were undertaken in a physiological buffer (RH), the RH influence has also been investigated. Thus, the stoichiometry and the stability constant of γ-CD or HP-γ-CD/DOX complex were determined in RH.
The stoichiometry of these inclusion complexes was provided by the continuous for γ-and HP-γ-CD/DOX complexes, respectively.
Transport studies of DOX alone. Before studying the influence of CDs on the transport of DOX across the BBB, the transport of DOX alone was performed. All experiments were carried out on our in vitro model of BBB presenting most of the in vivo BBB characteristics (Cecchelli et al., 1999) . DOX at varying concentrations was added on the luminal side of the monolayer of BCEC and the DOX transport was observed after a 120min-incubation. The results were expressed by using the endothelial permeability coefficient for DOX (Pe (DOX) ).
Using the same procedure, the integrity of the BCEC monolayer was checked by adding measure the reversal activity of S9788 on P-gp, BCEC were incubated with DOX, γ-CD or HP-γ-CD either alone or with S9788 ; and in each case Pe (DOX) or Pe (CD) and Pe (inulin) are presented in figure 3. 1 µM was chosen for S9788 because it has already been used for in vitro experiments in this BBB model (Fenart et al., 1998) . As a control experiment, 1 µM of S9788 was incubated on BCEC and the BBB integrity was preserved as shown by inulin permeability (0.15 x 10 -3 cm/min). In presence of S9788 and DOX (1 µM), Pe (DOX) and Pe (inulin) increased by a factor 2.2 and 4.5 respectively in comparisons with DOX alone. This result shows clearly that DOX transport is increased in presence of a P-gp inhibitor but this increase is due to a loss of BBB integrity. In this case, the threshold of DOX toxicity is decreased. No change in Pe (CD) and Pe (inulin) was observed for a coincubation of γ-CD or HP-γ-CD (1 mM) and S9788. Therefore, we can conclude that these two CDs are unlikely to be Pgp substrates.
Transendothelial transport studies of DOX in presence of γ-CD or HP-γ-CD. To evaluate the ability of CD/DOX to modify the brain delivery of DOX, the DOX concentration was fixed at 1 µM to avoid any toxic effect towards the integrity of the BBB. Amount of CD added has been chosen in function of percentage of free or complexed DOX. Table 1 summarizes the different percentages in CD or DOX used, according to the initial CD concentration and association constant. A high ratio CD/DOX led to a low free DOX concentration. In order to complex 90% of DOX, the CD concentration must be equal to 10 mM and 35 mM for γ-CD and HP-γ-CD respectively. In these cases, the percentage of free CD is greater than 99.5%. 
Discussion
In this work, γ-CD or HP-γ-CD has been employed to increase DOX transport across the BBB. The transport of DOX alone was first examined. At low doses from 1 to 10 µM, DOX crosses slightly the BBB. These low permeabilities could be explained by the presence of P-gp. Indeed, DOX is a P-gp substrate and so actively pumped out the BCEC as shown by Fenart et al. (1998) and confirmed by the experiments with a P-gp inhibitor (figure 3).
Nevertheless, our results can not exclude that the breast cancer resistance protein (BCRP/ABCG2) may also play a role in the disposition of DOX in our cell system. Indeed, this protein has been recently detected at the BBB and acts as a drug efflux pump (Eisenblatter et al., 2003; Cisterino et al., 2004) . Moreover, DOX has been recently described as a BCRP substrate (Han and Zhang, 2004) . At higher doses (> 20 µM), we observe that DOX reached the brain compartment due to the BBB breakdown as indicated by Pe (Inulin) .
DOX accumulates in the BCEC nucleus as shown by our fluorescence study (data not shown) and this accumulation leads to a BBB disruption. Indeed, DOX is capable of generating a variety of free radical species which are toxic for the cells (Keizer et al., 1990; Leblanc et al., 1991) .
The transport of γ-and HP-γ-CD alone was studied. The Pe of each CD is relatively similar but the toxicity towards the BBB integrity is two-fold lower for HP-γ-CD. The insight of toxicity is probably related to interactions between CDs and membrane lipids. Indeed, as shown on our in vitro BBB model, γ-CD is able to extract cholesterol (13% compared to control) and phospholipids (20% compared to control) from BCEC membranes (Monnaert et al., 2004) . Furthermore, a marked reduced toxicity for HP-γ-CD in comparison with γ-CD has already been described towards P388 murine leukaemia cells (Leroy-Lechat et al., 1994) .
Then, the association between CD and DOX has been performed to increase the DOX transport to the brain. The abrupt increase in DOX delivery in presence of each CD is directly related to the opening of the BBB tight junctions as indicated by Pe (Inulin) and This article has not been copyedited and formatted. The final version may differ from this version. immunostainings. This opening corresponds to concentrations where each CD alone leads to a loss of BBB integrity and no effect on P-gp inhibition by CD is observed. So, this increase in DOX concentration into the brain compartment is directly related to CD toxicity and no supplementary toxic effect due to DOX was observed. As already described above, lipid effluxes by CD was probably responsible for this BBB breakdown. In non-toxic conditions, the behaviour of γ-and HP-γ-CD is almost similar. The complexation of DOX decreases its transport to the brain and its toxicity towards BCEC. This phenomenon shows clearly that the inclusion complex does not improve the DOX transport and so that only the free DOX is available. A similar behaviour has been observed with the association of flutamide (used in prostate cancer chemotherapy) and HP-β-CD using the Caco-2 in vitro model (Zuo et al., 2000) . The permeability coefficient for this drug across a Caco-2 cell monolayer increased when HP-β-CD concentrations were reduced indicating that the passage was due to freely available flutamide.
So, the increase in DOX delivery in presence of CDs is due to the loss of BBB integrity. These results could be compared with studies performed on a Caco-2 cell monolayer which is often employed to predict toxicity or permeability for a drug towards the BBB.
Indeed, CDs are able to increase the delivery or bioavailability of drugs in the Caco-2 cell system. Arima et al. (2001) reported the enhancing effect of dimethyl-β-CD on the oral bioavailability of tacrolimus in Caco-2 cells. In addition, dimethyl-β-CD and HP-β-CD exhibited 22-fold and 19-fold permeability coefficient enhancement of cosalane (a potent inhibitor of HIV) respectively (Udata et al, 2003) . The authors concluded that CDs can promote transport by altering membrane fluidity with a minimal disruption of cellular barrier.
These selected results and others (for examples, see Hovgaard and Brondsted, 1995; Ventura et al., 2003) show without ambiguity the beneficial effect of CD to increase drug delivery on in Caco-2 cell monolayers. So, as already described by Lundquist et al. (2002) , our study reinforces the fact that correlation between Caco-2 and BBB model must be proscribed. BCEC are more sensitive and contrary to other cell systems only a slight extraction and/or reorganization of the membrane components is acceptable else a loss of BBB integrity occurs.
In conclusion, the use of γ-CD or HP-γ-CD, at non-toxic concentrations, does not increase the DOX delivery to the brain. Moreover, as DOX and the CDs used form inclusion complexes, DOX delivery appears to be decreased. So, CDs could slightly modify the BBB fluidity in order to increase the delivery of non complexed drug. Other experiments are running to study the co-administration of a CD and a drug which do not associate.
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